Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The purpose of this study is to determine the safety and speed of onset of 2mg intravenous hydromorphone (Dilaudid) in patients weighing at least 150 lbs presenting to the emergency department with acute severe pain
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
21 Years to 65 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Age greater than 21 years
Age less than 65 years of age
Pain with onset within 7 days
ED attending physician's judgment that patient's pain warrants use of morphine
Normal mental status
Prior use of methadone
Use of other opioids or tramadol within past seven days